-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
Amount of deferred income tax expense (benefit) pertaining to income (loss) from continuing operations.
-
Summary
-
LAVA Medtech Acquisition Corp. annual/quarterly Deferred Income Tax Expense (Benefit) history and growth rate from 2021 to 2022.
- LAVA Medtech Acquisition Corp. Deferred Income Tax Expense (Benefit) for the quarter ending March 31, 2022 was $9.09K.
- LAVA Medtech Acquisition Corp. annual Deferred Income Tax Expense (Benefit) for 2022 was $19.2K, unchanged from 2021.
Deferred Income Tax Expense (Benefit), Annual (USD)
Deferred Income Tax Expense (Benefit), YoY Annual Growth (%)